These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23041421)

  • 1. A human TOP2A core DNA binding X-ray structure reveals topoisomerase subunit dynamics and a potential mechanism for SUMO modulation of decatenation.
    Higgins NP
    J Mol Biol; 2012 Dec; 424(3-4):105-8. PubMed ID: 23041421
    [No Abstract]   [Full Text] [Related]  

  • 2. The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.
    Wendorff TJ; Schmidt BH; Heslop P; Austin CA; Berger JM
    J Mol Biol; 2012 Dec; 424(3-4):109-24. PubMed ID: 22841979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DNA Topoisomerase Type IIα (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study.
    Abu Saleh M; Solayman M; Hoque MM; Khan MA; Sarwar MG; Halim MA
    Biomed Res Int; 2016; 2016():6817502. PubMed ID: 27088089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II) polypyridyl complexes with 1,8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα.
    Sun Y; Li J; Zhao H; Tan L
    J Inorg Biochem; 2016 Oct; 163():88-94. PubMed ID: 27470011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases IIα and IIβ in vertebrate mitochondria.
    Zhang H; Zhang YW; Yasukawa T; Dalla Rosa I; Khiati S; Pommier Y
    Nucleic Acids Res; 2014 Jun; 42(11):7259-67. PubMed ID: 24803675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity.
    Schmidt BH; Osheroff N; Berger JM
    Nat Struct Mol Biol; 2012 Nov; 19(11):1147-54. PubMed ID: 23022727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase IIα in chromosome instability and personalized cancer therapy.
    Chen T; Sun Y; Ji P; Kopetz S; Zhang W
    Oncogene; 2015 Jul; 34(31):4019-31. PubMed ID: 25328138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
    Sai Krishna AD; Panda G; Kondapi AK
    Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients.
    Heestand GM; Schwaederle M; Gatalica Z; Arguello D; Kurzrock R
    Eur J Cancer; 2017 Sep; 83():80-87. PubMed ID: 28728050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
    Kawano S; Kato Y; Okada N; Sano K; Tsutsui K; Tsutsui KM; Ikeda S
    J Biochem; 2016 Mar; 159(3):363-9. PubMed ID: 26527691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.
    Drwal MN; Marinello J; Manzo SG; Wakelin LP; Capranico G; Griffith R
    PLoS One; 2014; 9(12):e114904. PubMed ID: 25489853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracyclines, HER2, and TOP2A: the verdict.
    Bonnefoi HR
    Lancet Oncol; 2011 Nov; 12(12):1084-5. PubMed ID: 21917520
    [No Abstract]   [Full Text] [Related]  

  • 14. C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase II alpha.
    Baweja L; Gurbani D; Shanker R; Pandey AK; Subramanian V; Dhawan A
    J Biomed Nanotechnol; 2011 Feb; 7(1):177-8. PubMed ID: 21485859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of ether-linked demethylepipodophyllotoxin dimers.
    Dunlap N; Salyard TLJ; Pathiranage AL; Stubblefield J; Pitts SL; Ashley RE; Osheroff N
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5627-5629. PubMed ID: 25466187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active DNA Olympic Hydrogels Driven by Topoisomerase Activity.
    Krajina BA; Zhu A; Heilshorn SC; Spakowitz AJ
    Phys Rev Lett; 2018 Oct; 121(14):148001. PubMed ID: 30339454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN stabilizes TOP2A and regulates the DNA decatenation.
    Kang X; Song C; Du X; Zhang C; Liu Y; Liang L; He J; Lamb K; Shen WH; Yin Y
    Sci Rep; 2015 Dec; 5():17873. PubMed ID: 26657567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα.
    Silveira-Dorta G; Sousa IJ; Ríos-Luci C; Martín VS; Fernandes MX; Padrón JM
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5382-4. PubMed ID: 23953196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II alpha is required for embryonic development and liver regeneration in zebrafish.
    Dovey M; Patton EE; Bowman T; North T; Goessling W; Zhou Y; Zon LI
    Mol Cell Biol; 2009 Jul; 29(13):3746-53. PubMed ID: 19380487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
    Dickey JS; Osheroff N
    Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.